Medical Properties Trust ...

NYSE: MPW · Real-Time Price · USD
4.11
-0.04 (-0.96%)
At close: Aug 15, 2025, 10:01 AM

Medical Properties Trust Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
921.83M 948.03M 995.55M 641.32M 722.07M 792.9M 871.8M 1.37B 1.42B 1.48B 1.54B 1.57B 1.61B 1.59B 1.54B 1.47B 1.41B 1.32B
Cost of Revenue
99.39M 29.47M 27.25M 20.77M 22.26M 39.27M 41.57M 45.97M 47.75M 44.21M 45.7M 45.83M 44.69M 42.24M 39.1M 36.98M 35.75M 24.93M
Gross Profit
822.44M 918.56M 968.29M 620.55M 699.81M 753.63M 830.23M 1.33B 1.37B 1.44B 1.5B 1.53B 1.57B 1.55B 1.51B 1.43B 1.37B 1.29B
Operating Income
107.95M 339.56M 386.85M 25.1M 45.77M -162.85M -102.9M 378.67M 603.55M 946.74M 1B 1.03B 1.07B 1.07B 1.04B 981.07M 941.33M 879.62M
Interest Income
713K 713K 713K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-1.39B -1.61B -2.36B -2.62B -1.7B -1.59B -686.77M -152.1M -38.45M 352.97M 959.72M 1.3B 1.24B 1.2B 730.89M 635.58M 600.92M 550.4M
Net Income
-1.43B -1.65B -2.41B -2.66B -1.74B -1.46B -556.48M -33.01M 72.08M 303.71M 902.6M 1.25B 1.2B 1.12B 656.02M 559.37M 519.34M 514.24M
Selling & General & Admin
133.22M 142.35M 133.79M 135.45M 136.94M 137.21M 145.59M 158.33M 157.54M 160.79M 160.49M 155.93M 155.3M 150.99M 145.64M 141.85M 136.88M 134.35M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
334.4M 436.64M 447.66M 460M 517.1M 691.98M 917.77M 1.17B 1.22B 1.28B 1.34B 1.37B 1.41B 1.4B 1.36B 1.29B 1.24B 1.16B
Operating Expenses
467.63M 579M 581.45M 595.45M 654.04M 829.19M 1.06B 1.33B 1.37B 1.44B 1.5B 1.53B 1.57B 1.55B 1.51B 1.43B 1.37B 1.29B
Interest Expense
-108.69M 108.55M 101.43M 316.36M 316.82M 319.86M 308.83M 308.83M 290.2M 273.46M 266.99M 266.99M 273.05M 277.62M 273.41M 273.41M 261.54M 249.61M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
567.01M 608.47M 608.7M 616.22M 676.3M 868.47M 1.1B 1.37B 1.42B 1.48B 1.54B 1.57B 1.61B 1.59B 1.54B 1.47B 1.41B 1.32B
Income Tax Expense
37.84M 42.59M 44.1M 38.52M 39.55M -123.27M -130.68M -119.38M -110.86M 48.06M 55.9M 45.42M 37.45M 76.97M 73.95M 75.37M 80.76M 35.41M
Shares Outstanding (Basic)
600.73M 600.59M 600.4M 600.23M 600.06M 600.3M 598.98M 598.44M 598.34M 598.3M 598.05M 598.98M 598.83M 598.68M 596.39M 595.12M 587.51M 576.24M
Shares Outstanding (Diluted)
600.73M 600.59M 600.4M 600.23M 600.06M 600.3M 598.98M 598.55M 598.34M 598.31M 598.05M 599.34M 599.03M 598.93M 596.66M 597.32M 589.05M 577.54M
EPS (Basic)
-2.39 -2.77 -4.03 -4.45 -2.92 -2.45 -0.94 -0.06 0.12 0.51 1.51 2.08 2.00 1.87 1.10 0.96 0.92 0.94
EPS (Diluted)
-2.39 -2.77 -4.03 -4.45 -2.92 -2.45 -0.94 -0.06 0.12 0.51 1.51 2.08 2.00 1.87 1.10 0.96 0.92 0.94
EBITDA
1.89B 1.59B 840.6M -1.38B -584.49M -202.93M 697.41M 554.77M 653.78M 747.8M 1.35B 1.98B 1.93B 1.89B 1.41B 1.35B 1.28B 1.2B
EBIT
1.49B 1.15B 386.85M -1.85B -926.13M -808.69M 81.28M -66.29M 28.73M 403.4M 1B 1.63B 1.58B 1.55B 1.07B 1.03B 976.61M 909.79M
Depreciation & Amortization
404.83M 441.97M 453.75M 467.47M 341.64M 605.75M 616.13M 621.06M 625.05M 344.4M 345.58M 348.38M 352.18M 343.94M 333.78M 321.26M 305.41M 290.73M